Tag: Motley Fool

Shares in Baby Bunting Group Ltd (ASX: BBN) have continued their trend upwards today to set yet another all-time high. Australia’s largest specialty retailer of baby goods has enjoyed a 165% rise in its share price over the last year.

At the end of Friday’s session, the Baby Bunting share price was $6.58, up 3.8%.

Results recap

The last lot of metrics to come out of the company were back in February. With the Baby Bunting share price surging since then, it might be worth taking a look again.

For the first half of FY21, the retailer achieved sales growth of 16.6% compared to the prior corresponding period (pcp) to $217.3 million. While earnings before interest, tax, depreciation, and amortisation (EBITDA) grew to $18.5 million – an increase of 29.7%.

Operating in what Baby Bunting describes as “a less discretionary category”, the company grew through a challenging period. During the first half, the company added 3 new stores and didn’t receive any JobKeeper payments.

Most notably, after a thorough assessment, Baby Bunting made the decision to expand to New Zealand. It now expects to open its first store in FY22, with plans of over 10 stores across the region.

It’s all good news, which explains the Baby Bunting share price rally. However, there is one potential ‘teething issue’ that could slow momentum.

Will fewer ‘customers’ affect Baby Bunting share price?

Australia’s birth rate has been in decline for several years. The natural increase in population was 3.8% lower than the previous year for the 12 months to September 2020.

Typically, Australia relies on immigration for its population growth. But with international borders remaining closed due to COVID-19, immigration inflows are non-existent.

Actual birth statistics are always lagging due to the arduous collection of data. As a result, we likely won’t know the full extent of birth rate impacts in Australia until the end of the year. Though, the longer border restrictions are in place, the bigger the birth deficit in Australia.

For now, the Baby Bunting share price and its shareholders are unfazed.

More reading

• 3 ASX retail shares at record highs
• 2 quality ASX shares rated as top buys by brokers
• Brokers think these 2 top ASX shares are buys in April 2021
• These top 2 ASX shares should be on your watchlist
• 2 ASX shares that may be hit by Australia’s declining birth rate

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Baby Bunting. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Baby Bunting (ASX:BBN) share price: all-time highs and potential teething issues appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3dK0wPP

One of the ways that legendary investor Warren Buffett has generated wealth over decades of investing is by buying and holding the shares of quality companies. This investment strategy is highly successful due to the power of compounding.

Compounding is interest on top of interest, or returns on top of returns for investments. It explains how an investment earning a 10% per annum return will double in value in a little over seven years.

With that in mind, listed below are two ASX shares that could be quality candidates for a buy and hold investment. Here’s what you need to know about them:

Altium Limited (ASX: ALU)

Altium is an award-winning printed circuit board (PCB) design software provider. PCBs are the circuit boards you find in almost all electronic devices. 

Given the proliferation of electronic devices globally and their complex designs, demand for its software has been growing very strongly over the last few years.

And while COVID-19 is hampering Altium’s growth and recently led to discounting, demand is expected to pick up again once the pandemic passes. 

Looking ahead, management continues to target subscriptions of 100,000 and revenue of US$500 million by FY 2025/26. This will be a big increase on FY 2020’s ~51,000 subscriptions and revenue of US$189.1 million.

Citi is positive on the company. It recently retained its buy rating and $33.50 price target on Altium’s shares.

Domino’s Pizza Enterprises Ltd (ASX: DMP)

Another quality candidate for a buy and hold investment could be Domino’s.

This is due to its talented management team and their long-term thinking. Domino’s may be smashing expectations in FY 2021 with some very impressive sales and profit growth, but that doesn’t distract it from thinking about the next decade.

Domino’s finished the first half of FY 2021 with a network of 2,800 stores. It is now aiming to double this by 2023 in its existing markets. Management is also looking for acquisitions and could expand into new territories in the future. This would give it an even longer runway for growth.

Morgans is very positive on the company’s future. The broker currently has an add rating and $119.00 price target on its shares.

More reading

• Why Zip (ASX:Z1P) and this ASX growth share are rated highly
• Altium (ASX:ALU) share price tumbles on broker downgrade
• Aussie dollar shoots higher! Here are some ASX winners
• Why Altium, Challenger, Lynas, & Sydney Airport shares are sinking
• Why the Altium (ASX:ALU) share price is sinking today but could rebound strongly

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Altium. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post How to invest like Warren Buffett with ASX shares appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3v5giL0

Goldman Sachs hosted its 4th small/mid-cap healthcare forum this week. This included 13 Australian and New Zealand healthcare companies across a diverse range of specialties. Here are the ASX healthcare shares that Goldman picked as a buy. 

Goldman’s ASX healthcare shares to buy

Opthea Ltd (ASX: OPT) 

Opthea is developing a complementary medicine to be used with existing inhibitors for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). 

Goldman believes there is multi-billion dollar potential in Opthea’s treatment. The broker observes that existing treatments only inhibit up to two of the factors responsible for retinal disease, with over half of patients not achieving significant vision gains and a quarter experiencing continued vision loss. 

The company’s lead candidate, OPT-302 is intended to complement existing treatments to produce an improved outcome for patients. 

Opthea successfully completed a A$169 million initial public offering on the US NASDAQ market in September 2020, improving its cash position to A$203 million in 1H21. Goldman believes this secures the company’s funding for the completion of two pivotal Phase 3 trials. 

Pro Medicus Limited (ASX: PME) 

Within the context of medical imaging, Goldman believes that “globally, there is rapidly growing demand for solutions that can process, transfer and store this data efficiently, particularly given that speed and accuracy is intrinsically linked to treatment outcomes and commercial incentives”.

Pro Medicus shares have been chugging along and up 33% year-to-date to a near all-time record high of $47.22.

Goldman has observed that its 3Q21 transaction volumes are tracking above pre-COVID levels with a strong backlog/deferral stream to provide growth for months to come.

Goldman has modelled “an average of 5 contract wins per year, at an average minimum size of A$15m pa, reflecting recent order momentum and our expectation of heightened interest in this technology through the coming periods “.

Integral Diagnostics Ltd (ASX: IDX) 

Integral Diagnostics is one of the largest diagnostic imaging companies in Australia.

Goldman observes that the company’s 1H21 growth of 6.5% was softer than the 8.3% improvement from Medicare.

This was largely driven by Integral’s geographical weighting in Victoria which was impacted by regional lockdowns. Looking ahead, the company has commented that volumes in the second half are growing in line with expectations. 

The growth drivers highlighted by Goldman and Integral include a “steady positive mix shift towards high-acuity imaging” and “Medicare reimbursement re-indexation from July-20 at c.+1.5% pa”.

More reading

• Why this ASX share bull market could run for longer
• 2 small cap ASX dividend shares to buy
• Why the Pro Medicus (ASX:PME) share price could be in the buy zone
• 2 excellent ASX shares to buy in April
• 3 great reasons to own Pro Medicus (ASX:PME) shares

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia has recommended Integral Diagnostics Ltd and Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post The ASX healthcare shares Goldman Sachs rates as a buy appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2QKnRrz

Retailers have stepped up their game to emerge as some of the top-performing ASX shares this week. 

Many of the top performers have not announced any market sensitive news or updates. This could reflect broader strength and investor interest coming into the seemingly overlooked retailers. 

The strong performance has also come about after many months of trading in a sideways fashion. These ASX shares have finally managed to break out spectacularly, many of which have hit new record highs. 

Here are the seemingly overlooked retailers that have topped the market.  

Adairs Ltd (ASX: ADH) 

The Adairs share price has cruised 10% higher this week to a record high of $4.90. The company has not released any market sensitive news besides an inclusion into the ASX300 on 12 March and half-year results on 16 February. 

Its shares have been consolidating between the $4.20 and $3.80 level since October 2020. But during this time, the ASX200 has managed to gain 15% from 6,150 to 7,055. Adairs finally managed to push above its trading range this week and just a fraction off $5.00. 

Eagers Automotive Ltd (ASX: APE) 

ASX automotive shares have received several broker upgrades following tailwinds, such as changing attitudes towards public transport and a potential increase in domestic travel via vehicles. 

Eagers Automotive shares climbed 8.60% this week to a record high of $16.80. Morgan Stanley, Morgans and UBS were all buy-rated on Eagers shares with an average target price of $17.10. 

Super Retail Group Ltd (ASX: SUL) 

Automotive and outdoor retailer Super Retail Group has also captured the tailwinds behind ASX automotive shares.

Super Retail shares are up 5.30% this week to $12.72 and about 7% shy of their previous high of $13.90 set in November 2013. In a similar fashion as Adairs, Super Retail Group has not announced any market sensitive news since its strong half-year results on 17 February. Its shares were chopping back and forth between $11.00 and $12.00 before a breakout this week. 

Nick Scali Limited (ASX: NCK)

Nick Scali shares added 4% this week to close at $11.02 today. Surprisingly, its share price resembles the tech sector’s timeline, experiencing a selloff during late February, hitting a near-term low in March before making a recovery in April. 

The company follows the theme so far with no market sensitive announcements besides a JobKeeper update on 8 February and half-year results on 4 February. 

Dusk Group Ltd (ASX: DSK)

The Dusk share price is up 5.2% this week to $3.63.

The company made its ASX debut on 2 November 2020 at an offer price of just $2.00 or a 70% return for those that participated in the initial public offering.

Surprisingly, a candle selling retail business has managed to outperform seemingly more exciting IPOs from last year, such as Adore Beauty Group Ltd (ASX: ABY), Laybuy Group Holdings Ltd (ASX: LBY) and MyDeal.com.au Ltd (ASX: MYD).

More reading

• 3 under the radar ASX small cap shares to watch closely
• Brokers name 2 quality ASX dividend shares to buy
• Why ASX 200 retail shares like Super Retail (ASX:SUL) are worth watching
• Brokers think these shares can outperform the ASX 200
• Laybuy (ASX:LBY) share price slides on Q4 trading update

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends ADAIRS FPO and Adore Beauty Group Limited. The Motley Fool Australia owns shares of and has recommended Super Retail Group Limited. The Motley Fool Australia has recommended ADAIRS FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why retailers are stepping up as top performing ASX shares this week appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3ayrQyw

The Chimeric Therapeutics Ltd (ASX: CHM) share price edged higher in the final hour, before falling flat today. This comes despite the company releasing its quarterly update to the ASX towards the latter part of the afternoon.

At the end of today’s market wrap, the biotechnology company’s shares finished the day flat at 28.5 cents.

How did Chimeric perform?

Investors led Chimeric shares to close the day unchanged despite the company recapping its achievements and providing a financial update.

In the release, Chimeric reported a number of highlights, signalling why its shares have surged since listing on the ASX.

Chimeric declared $23.6 million in cash at the end of the March quarter. This is a significant increase from the $65,000 achieved at 31 December 2020. The company noted the funds will be used to progress its clinical trials of CLTX CAR T and begin the development of a cell therapy pipeline.

The net cash used in operating activities stood at $5.4 million, predominately due to the one-off fee paid to the City of Hope. This compares to the $1.9 million recorded in the prior quarter. Most of the fees were allocated towards change of control fee, administrative and corporate costs.

Net cash used in investing activities totalled $2.6 million, which was relatively in line with the December quarter. The payment relates to the second instalment to the City of Hope licence agreement.

The company re-touched on its CLTX CAR T clinical trials, with the second patient cohort now commencing a higher dosing level.

In addition, Chimeric reverted back to its significant management appointments in which several distinguished experts joined the board.

Chimeric share price summary

While the company is still relatively new on the ASX boards, the Chimeric share price moved between the 28 cents and 44 cents range. The company’s shares hit its all-time in the same week of its listing.

On valuation metrics, Chimeric presides a market capitalisation of roughly $56.3 million, with 196.5 million shares on issue.

More reading

• Chimeric (ASX:CHM) share price edges lower despite positive update

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Chimeric (ASX:CHM) share price finishes flat on quarterly update appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3gBPsWK

It’s TGIF time once again, and investors with shares in a select 3 S&P/ASX 200 Index (ASX: XJO) companies have something to celebrate this weekend.

Here are the 3 ASX 200 shares that outperformed all others this week.

Monadelphous Group Limited (ASX: MND) – up 9.44%

The best ASX 200 performer of the week was Monadelphous, which recorded a 9.44% share price gain. Its shares are now trading for $12.41.

The company released no new news this week, although it was on our radar last Friday after it settled a lawsuit with Rio Tinto outside of court. Perhaps, that’s been driving its share price this week.

Rio Tinto launched proceedings against Monadelphous in August last year, claiming $493 million in damages. The charges related to a fire that began at Rio Tinto’s iron ore processing plant in Cape Lambert during maintenance procedures managed by Monadelphous.

Luckily for Monadelphous, the charges were dropped, and its share price seems to be rejoicing.

Megaport Ltd (ASX: MP1) – up 9.48%

The Megaport share price enjoyed a positive week, up 9.48% to close today at $13.51.

Most of the software-defined network service provider’s share gains came after it released its quarterly report. The report showed consistent growth across all of Megaport’s metrics, including its monthly reoccurring revenue, which increased by 8% quarter-on-quarter (QoQ). 

Within its results, Megaport announced it gained 74 new corporate customers in the quarter ending March 31.

Hub24 Ltd (ASX: HUB) – up 7.8%

Finally, the third-best performing share price in the ASX 200 this week is Hub24. Its gains also seem to have been brought about by its quarterly results. Currently, the Hub24 share price trading at $25.50, up 7.8%.

Hub24 announced a 41% increase to its cash flow in the quarter just been, with the company raking in $1.9 billion. During the 2021 financial year, its average monthly net inflows were $556 million, up 35% from last financial year’s monthly average.

It also announced it now owns 33% of Easton Investments Ltd (ASX: EAS) shares.

More reading

• ASX 200 recovers, Redbubble sinks, Megaport jumps
• Why Megaport, Pointerra, Regis Resources, & Zip are charging higher
• ASX 200 up 0.2%: AMP sinks, Redbubble crashes, Megaport jumps
• Megaport (ASX:MP1) share price in spotlight following Q3 update
• 2 highly rated ASX growth shares

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MEGAPORT FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Hub24 Ltd. The Motley Fool Australia has recommended Hub24 Ltd and MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Which ASX 200 shares were the best performers this week? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3gyoOOs

The Australian share market is home to a good number of high quality companies with strong business models.

Among the best of them are arguably the shares listed below. Here’s why these ASX shares could be quality options for investors right now:

CSL Limited (ASX: CSL)

The first ASX share to consider is CSL. While this leading biotechnology company would be a top option at most times, now appears to be a particularly good time to make an investment. This is due to a recent and sharp pullback in the CSL share price.

This weakness has been driven by plasma collection headwinds caused by the pandemic. The good news is that increased demand for flu vaccines from the Seqirus business looks set to offset much or even all of this. And with plasma collections expected to improve once the pandemic passes, CSL appears well-placed for growth once conditions ease.

This should be supported by its lucrative R&D pipeline, which is filled with a number of potentially lucrative therapies that could be launched in the not so distant future. One of those is Clazakizumab. It is a humanised recombinant monoclonal antibody targeting interleukin-6 for the potential treatment of chronic active antibody-mediated rejection. This is the leading cause of long-term rejection in kidney transplant recipients. If successful, peak sales are estimated to be US$5.4 billion per annum.

Citi currently has a buy rating and $310 price target on its shares.

Xero Limited (ASX: XRO)

Another option to consider is Xero. This cloud-based business and accounting platform provider has been growing strongly over the last few years.

This has been driven by the shift to the cloud, its international expansion, acquisitions, increasing revenue per user, and its evolution into a full service solution.

The good news is that these same trends look set to underpin further strong growth over the next decade. This should be supported by its burgeoning app ecosystem, which Goldman Sachs is incredibly positive on.

According to a note, the broker estimates that Xero has a core total addressable market (TAM) of NZ$14 billion across its key markets. However, if it can successfully broaden and monetise its app ecosystem and expand into new geographies, Goldman believe it would open a further NZ$62 billion in TAM. As a result, it believes Xero has “a multi-decade runway for strong revenue growth.”

Goldman Sachs has a buy rating and $153.00 price target on its shares.

More reading

• Why the CSL (ASX:CSL) share price has rebounded 13% since March
• AUSSIE-FIRST: How to buy a fraction of an ASX share
• 2 five-star ASX 200 shares that are rated very highly
• Aussie dollar shoots higher! Here are some ASX winners
• CSL (ASX:CSL) share price wobbles on plasma and vaccine update

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 of the best ASX 200 shares according to analysts appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3tOeINs

The Telstra Corporation Ltd (ASX: TLS) share price has had an interesting week. Telstra shares started Monday off at a price of $3.42 a share. But by Wednesday, those same shares dipped to as low as $3.32, a fall of more than 3% from Monday’s level. By the end of the week, we saw Telstra return to a share price of $3.40.

That was despite some interesting developments along the way. On Thursday, we discussed how Pengana Capital holds Telstra shares as its biggest holding. As my Fool colleague Tony reported, Pengana Capital chief investment officer Rhett Kessler has Telstra “as just under 8% of our portfolio”. Why? Mr Kessler stated that Pengana likes the telco because “when you buy Telstra shares, you’re buying the best mobile phone network in the country. And you’re buying a really nice inflation-protection bond from the government”.

Telstra gets 5G boost

On Friday, it was revealed that Telstra has secured 1,000 MHz in the 26 GHz spectrum auction, spending $277 million to do so.

Here’s some of what Telstra CEO Andy Penn said of the acquisition:

Telstra is already leading the way in 5G, and this investment of $277 million in highly sought after spectrum will help us broaden and deepen our 5G connectivity for more Australians across the country…. mmWave spectrum is especially good at providing high-speed mobile broadband in high-density areas, such as built up cities and towns, train stations, sport stadiums and other locations with a high concentration of people using their mobile devices.

So what’s next for the Telstra share price? Well, Telstra has been hovering around its current pricing level since late March. Before then, the telco had been on a bit of a bullish run, appreciating more than 12% between 11 March and 30 March. This share price run was sparked by Telstra’s announced plans to structurally separate itself into 4 divisions by December this year. Investors are evidently expecting that this separation will unlock value from some of Telstra’s more defensive assets. Such as its mobile towers and fixed-line networks.

Considering all of this, it will be interesting to see how the market continues to price Telstra. The separation plans are likely to continue to set the tone for the company. Especially in conjunction with the 5G spectrum announcement on Friday.

More reading

• ASX 200 finishes flat, Kogan drops, Accent jumps
• What’s with the Telstra (ASX:TLS) share price and other telcos today?
• History is on the side of the battered AMP (ASX:AMP) share price as it plans its demerger
• ASX 200 down 0.1%: Kogan crashes, AMP’s demerger plans, Telstra strengthens 5G network
• Telstra (ASX:TLS) share price on watch after 5G update

Motley Fool contributor Sebastian Bowen owns shares of Telstra Limited. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post What’s next for the Telstra (ASX:TLS) share price? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3sEZTLv

The IGO Ltd (ASX: IGO) share price spent all day firmly in the green today. At the close of trade, shares in the mineral exploration company were swapping hands for $7.13, up 2.5%.

Today’s positive price movement comes amid news the company has successfully divested its minority stake in a gold mining project.

Let’s take a closer look at today’s news and what it means for the IGO share price.

IGO offloads Tropicana investment

In a statement to the ASX, IGO advised it has sold its 30% stake in the Tropicana Gold Mine to Regis Resources Limited (ASX: RRL). The sale was pending confirmation from Tropicana majority owner, AngloGold Ashanti (ASX: AGG). This approval was received yesterday.

The divestment of Tropicana marks “an important strategic milestone” for IGO.

The company said the transaction maximised the value of Tropicana for IGO’s shareholders and allowed it to focus on commodities critical to enabling clean energy. Investors seemingly agree, judging by today’s IGO share price rise.

Proceeds from the sale will be used to fund the purchase of the Tianqi Lithium Corporation’s Australian lithium assets.

Lithium demand continues 

It’s no secret that Lithium shares have been soaring in recent months. Strong demand for the element is linked to rising demand for electric vehicles – which use lithium in their batteries.

The website Trading Economics puts the price of lithium on the open market at approximately US $14,000 a tonne. It’s up an astonishing 93.6% since the beginning of the year. Other metals surging on the green energy boom include cobalt, copper, nickel, palladium, platinum, and rhodium.

In other news affecting the IGO share price recently, Antipa Minerals Ltd (ASX: AZY) announced the Burracoppin Project (which it has a 30% interest in) has “encouraging” essay results.

The best results, according to Antipa, include a 1-metre-wide ore with 7.48g of gold per tonne and an 8-metre-wide ore with 0.47g of gold per tonne.

IGO share price snapshot

Over the past year, the IGO share price has increased 55.57% and posted a 65.17% rise in 2021.

IGO Ltd has a market capitalisation of $5.4 billion.

More reading

• The ASX 200 shares brokers think you should watch out for
• Why Megaport, Pointerra, Regis Resources, & Zip are charging higher
• ASX 200 shares thrown in the bargain bin: Here’s 3 ideas
• Why the Regis Resources (ASX:RRL) share price is climbing
• ASX 200 Weekly Wrap: ASX 200 hits new post-COVID high

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post IGO (ASX:IGO) share price lifts on latest updates appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3axerqz

If you’re looking for outsized returns, then the small cap side of the market could be worth a look.

This is because there are a number of small caps that could generate very strong returns for investors over the 2020s if they live up to their potential.

Two small cap ASX shares that are highly rated are listed below. Here’s what you need to know about them:

Bigtincan Holdings Ltd (ASX: BTH)

The first small cap to look at is this provider of an artificial intelligence-powered sales enablement automation platform.

Sales enablement may not be a term that many readers are overly familiar with. However, it is simply a platform that enables sales teams to function more efficiently and deliver better results.

Clearly the platform works, as Bigtincan continues to experience strong demand from some of the biggest companies in the world.

The company has also been making bolt-on acquisitions which have improved its offering and strengthened its position in particular industries.

A combination of the benefits of acquisitions and organic growth led to the company reporting annualised recurring revenue (ARR) of $48.4 million at the end of December. This was a 50% increase over the prior corresponding period.

Morgan Stanley is a fan of the company. It currently has an overweight rating and $1.40 price target on its shares.

Booktopia Group Ltd (ASX: BKG)

Another small cap to watch is this online book retailer.

Like Bigtincan, it has been growing very strongly in FY 2021. This has been driven by the shift online and improvements in its distribution capabilities.

For example, during the first half of FY 2021, the company reported a 40% jump in shipments to a total of 4.2 million units. This ultimately led to Booktopia reporting a 51.1% increase in revenue to $112.6 million and a whopping 502.3% jump in underlying EBITDA to $8 million.

Analysts at Morgans are fans of the company and believe it is well-placed for further growth. They currently have an add rating and $3.53 price target on its shares.

More reading

• 2 rapidly growing small cap ASX shares to watch
• 3 excellent small cap ASX shares to watch closely
• 3 exciting small cap ASX shares to watch
• Why the Booktopia (ASX:BKG) share price is climbing today
• 2 quality small cap ASX shares rated as buys

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends BIGTINCAN FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Booktopia Group Limited. The Motley Fool Australia has recommended BIGTINCAN FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 highly rated small cap ASX shares you need to know appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3dHkcUo